My Treatment Approach: Improving Chronic Lymphocytic Leukemia Management and Treatment Outcomes - Episode 8
Strategies for Optimizing Venetoclax-Based Treatment for Patients with CLL
John N. Allan, MD, provides clinical insights on how appropriate dose ramp-up practices for venetoclax can minimize adverse events and optimize patient outcomes.
Video content above is prompted by the following questions:
- Explore the logistics and best practices aimed at optimizing therapeutic response, minimizing potential adverse events, and maximizing off-treatment benefits.
- How do you initiate venetoclax therapy in your practice, including titration and management of potential AEs and risk of tumor lysis syndrome?
- What insights/implications do recent real-world data provide?